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Abstract
Epidemiological studies have shown an inverse correlation between the incidence of lymphatic filariasis (LF) and the
incidence of allergies and autoimmunity. However, the interrelationship between LF and type-2 diabetes is not known and
hence, a cross sectional study to assess the baseline prevalence and the correlates of sero-positivity of LF among diabetic
subjects was carried out (n=1416) as part of the CURES study. There was a significant decrease in the prevalence of LF
among diabetic subjects (both newly diagnosed [5.7%] and those under treatment [4.3%]) compared to pre-diabetic
subjects [9.1%] (p=0.0095) and non-diabetic subjects [10.4%] (p=0.0463). A significant decrease in filarial antigen load
(p=0.04) was also seen among diabetic subjects. Serum cytokine levels of the pro-inflammatory cytokines—IL-6 and GM-
CSF—were significantly lower in diabetic subjects who were LF positive, compared to those who were LF negative. There
were, however, no significant differences in the levels of anti-inflammatory cytokines—IL-10, IL-13 and TGF-b—between the
two groups. Although a direct causal link has yet to be shown, there appears to be a striking inverse relationship between
the prevalence of LF and diabetes, which is reflected by a diminished pro-inflammatory cytokine response in Asian Indians
with diabetes and concomitant LF.
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Introduction
Global epidemiological studies have shown a marked increase in
the incidence of diabetes worldwide. India leads the world in
absolute numbers of diabetic subjects [1]. Type-2 diabetes mellitus
constitutes about ,90% of the entire diabetic population. The
association between diabetes mellitus and increased susceptibility
to infections is well known. Many diseases such as tuberculosis and
candidiasis are more common in diabetic patients, while some
such as invasive otitis externa and rhinocerebral mucomycosis
occur almost exclusively in people with diabetes [2]. In addition,
infections with group B streptococcus and Klebsiella spp. occur
with increased severity in patients with diabetes and may be
associated with an increased risk of complications [2].
Infection with systemic helminths, in addition to causing
morbidity by themselves, may contribute to increased morbidity
due to diabetes. But, there is very little data available on the
prevalence of lymphatic filariasis (LF) among people with diabetes,
although studies have examined the coexistence of LF with HIV
[3], malaria [4] and tuberculosis [5]. Current estimates suggest
that 129 million persons worldwide are infected with one of the
three lymph-dwelling filariae (Wuchereria bancrofti, Brugia malayi or B.
timori), the major causative agents of LF. The disease burden from
LF is concentrated in tropical and sub-tropical countries (such as
India) where the prevalence of type-2 diabetes is greatest [6]. This
is particularly true in South India where the prevalence of LF
caused by W. bancrofti is between 6–20% based on circulating
filarial antigenemia [5]. Thus, in the present study, the influence of
LF on diabetes was examined as part of an ongoing, prospective
epidemiological study in Chennai, Southern India.
Methods
Study subjects
Institutional ethical committee approval from the Madras
Diabetes Research Foundation Ethics Committee was obtained
(Ref No-MDRF-EC/SOC/2009//05) and written informed
consent was obtained from all the study subjects. Study subjects
were recruited from the Chennai Urban Rural Epidemiology
Study (CURES), an ongoing epidemiological study conducted on
a representative population of Chennai (formerly Madras), the
fourth largest city in India. The methodology of the study and the
www.plosntds.org 1 June 2010 | Volume 4 | Issue 6 | e707prevalence of diabetes in Chennai have been published elsewhere
[7,8]. Briefly, in Phase 1 of the urban component of CURES,
26,001 individuals were recruited based on a systematic sampling
technique with random start. Fasting capillary blood glucose was
determined using the OneTouch Basic glucometer (Lifescan,
Johnson & Johnson, Milpitas, CA) in all subjects. Details of
the sampling are described on our website (http://www.
drmohansdiabetes.com/bio/WORLD/pages/pages/chennai.html).
In Phase 2, detailed studies of diabetic complications, including
nephropathy and retinopathy, were performed, and in Phase 3,
every 10
th individual in Phase 1 was invited to participate in more
detailed studies. As part of the questionnaire, the socio-economic
details of the study participants was collected and recorded. For the
present study, the following groups were randomly selected from
Phase 3 of CURES, Group 1- 943 normal glucose tolerance subjects
(NGT); Group 2- 154 subjects with impaired glucose tolerance
(IGT); Group 3- 158 newly diagnosed type-2 diabetes subjects (ND-
DM) and Group 4- 161 known type-2 diabetes subjects under
treatment (KDM). A larger NGT group was included based on
sample size calculations and to obtain baseline values for the normal
population. The filarial status of these individuals was not known at
the time of recruitment into the study.
Anthropometric and biochemical parameters
Anthropometric measurements, including height, weight, and
waist circumference, were obtained using standardized techniques.
The body mass index (BMI) was calculated as the weight in
kilograms divided by the square of height in meters. Fasting
plasma glucose (FPG) (glucose oxidase-peroxidase method), serum
cholesterol (cholesterol oxidase-peroxidase- amidopyrine method),
serum triglycerides (glycerol phosphate oxidase-peroxidase-ami-
dopyrine method), high density lipoprotein cholesterol (HDL-C)
(direct method-polyethylene glycol-pretreated enzymes), and
creatinine (Jaffe’s method) were measured using a Hitachi-912
Autoanalyser (Hitachi, Mannheim, Germany). The intra- and
inter assay coefficient of variation for the biochemical assays
ranged between 3.1% and 5.6%. Glycated hemoglobin (HbA1c)
was estimated by high pressure liquid chromatography using a
variant machine (Bio-Rad, Hercules, CA). The intra- and inter-
assay coefficient of variation of HbA1c was less than 5%.
Detection of bancroftian LF
To quantify the filarial antigen levels and prevalence, sera were
analyzed using the W. bancrofti Og4C3 antigen-capture enzyme-
linked immunosorbent assay (Tropbio, James Cook University,
Townsville, Queensland, Australia) according to the manufactur-
er’s instructions.
Determination of anti-filarial antibody titer
The serum antibody (IgG and IgG4) titer against Brugia malayi
antigen (BmA) was determined by ELISA as described previously
[9].
Determination of serum cytokine levels
The levels of cytokines (TNF-a, IL-6, IL-1b, GM-CSF, IFN-c,
IL-13 and IL-10) in the undiluted serum were measured using a
Bioplex multiplex cytokine assay system (Biorad, Hercules, CA).
The lowest detection limit for the various cytokines were IL-1b -
2.7pg/ml, IL-2-1.16 pg/ml, IL-4-0.3 pg/ml, IL-5- 2.08 pg/ml,
IL-6- 2.31 pg/ml, IL-10- 2.2 pg/ml, IL-12- 2.78 pg/ml, IL-13-
2.22 pg/ml, IL-17 2.57, GM-CSF- 0.67 pg/ml, IFN-c- 2.14 pg/
ml and TNF-a- 4.89 pg/ml. TGF-b was estimated by conven-
tional ELISA following manufacturer’s protocol (R&D, Minnea-
polis, MN). The lowest detection limit for TGF-b was 7.8 pg/ml.
Statistical analysis
All statistical analyses were performed using SPSS software
(Version 15.0.0, Chicago).The prevalence of filarial infections
among the different groups was analyzed by Pearson’s Chi-Square
test. The antigenic load and antibody titers were analyzed by
Mann Whitney U test. The clinical and biochemical character-
istics of the study subjects were compared using one-way ANOVA
analysis. To account for multiple comparisons, the cytokine levels
in controls (DM
2LF
2), DM
+LF
+ and DM
+LF
2 groups were
compared by multinomial logistic regression analysis. P va-
lues,than 0.05 were considered significant.
Results
Study population characteristics
The baseline characteristics including demographics, clinical
and biochemical features of the study population are shown in
Table 1. As can be seen in the table, compared to subjects with
normal glucose tolerance (NGT), those with glucose intolerance
(i.e. IGT, ND-DM, KDM) had higher BMIs, systolic and diastolic
blood pressure, serum cholesterol, LDL and triglycerides levels but
lower HDL cholesterol levels. Since, socio-economic differences
could be a confounding factor for the prevalence of both diabetes
[10] and LF [11], the average monthly income of study subjects
was recorded (Table 2). We also examined the occupation profile
of the study subjects (Table S1). As can be seen, there were no
significant differences in the socio-economic status between the
various groups.
Prevalence of LF
The prevalence of LF among the various groups was
determined by quantitative TropBio ELISA (.128 U/ml) and
Author Summary
Childhood helminth infections can reduce the risk and
severity of allergies and autoimmune diseases, by means
of immunomodulation, and a decrease in helminth
infections could potentially account for the increased
prevalence of these diseases in the western world (hygiene
hypothesis). We hypothesized that the same immuno-
modulatory effect can have an impact on metabolic
diseases like obesity, diabetes, hypertension and athero-
sclerosis, wherein inflammation plays a crucial role
(extended hygiene hypothesis). To test this hypothesis,
we examined the prevalence of lymphatic filariasis (LF)
among diabetic, pre-diabetic and non-diabetic subjects
who were part of the CURES (Chennai Urban Rural
Epidemiology Study) study. In accordance with our
hypothesis, we found reduced prevalence of LF among
diabetic subjects compared to non-diabetic and pre-
diabetic subjects. This was associated with decreased
filarial antigen load and anti-filarial antibody levels. The
association remained significant even after adjusting for
socioeconomic status, age and gender. Interestingly,
within the diabetic subjects, those who were filarial
positive had reduced levels of pro-inflammatory markers
(TNF-a, IL-6 and GM-CSF) compared to those who were
filarial negative. In light of these findings, the decreasing
incidence of filarial infection due to mass drug adminis-
tration could potentially have an unexpected adverse
impact on the prevalence of diabetes in India.
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observed. The prevalence of LF was found to be 10.4% in the
NGT, 9.1% in IGT, 5.7% in ND-DM and 4.3% in KDM
respectively. The differences in the prevalence rate between NGT
and KDM (p=0.0463) and NGT and ND-DM (p=0.0095) were
significant (Fig 1a).
Decreased circulating filarial antigen levels and
decreased anti-filarial antibody titer among type-2
diabetes subjects
To examine more quantitatively the association of type-2
diabetes and LF, we next quantified the serum circulating filarial
antigen (CFA) levels among the filarial positive subjects. Not only
was there a difference in prevalence rates between those with
NGT and those with glucose intolerance but there was also a clear
difference in the absolute levels of CFA in the LF-infected
individuals, with CFA levels being lower among the diabetic
groups compared to the NGT group (Fig 1b). The geometric mean
(range) of CFA levels in the four groups were: NGT-1,594 (127–
32,768), IGT-1,520 (209–16,345), ND-DM-929 (129–32,768) and
KDM-351 (163–1,126) with the differences in the antigen levels
between the KDM and the NGT (p=0.04) and the KDM and the
IGT (p=0.04) being statistically significant.
We next quantified the serum anti-filarial antibody levels among
those with LF in the four groups (Fig 2). Even though the mean
IgG4 levels were not different among the four groups, the mean
IgG levels were significantly lower in the KDM compared to NGT
(p,0.0023),
Differential serum cytokine profile in subjects with type-2
diabetes and/or LF
We next quantified pro- and anti-inflammatory cytokine levels
among control (DM
2LF
2), diabetic only (DM
+LF
2) or both LF
and diabetic (DM
+LF
+) subjects (Fig 3). In comparison to controls,
the diabetes only (DM
+LF
2) group had high levels of IL-6 and
GM-CSF, which was significant (p,0.01) (Fig 3b and c). There
was no significant difference in the levels of TNF- a (Fig 3a). In
DM
+LF
+ subjects, there was a significant reduction in the levels of
IL-6 and GM-CSF compared to the diabetic only group
(DM
+LF
2) (geometric mean (GM) of 13.57 pg/ml versus
45.13 pg/ml for IL-6, p,0.05; and GM of 0.81 pg/ml versus
2.24 pg/ml for GM-CSF, p,0.05). TNF- a levels were not
significantly different between the two groups. IL-1b levels were
not statistically different among the three groups (data not shown).
IFN-c levels were significantly elevated in diabetic only group
compared to controls but was unaltered by the LF status (Fig 3d).
When the levels of anti-inflammatory cytokines were measured,
both the diabetic groups (DM
2LF
+ and DM
+LF
+) had compara-
ble levels of IL-13 and TGF-b (Fig 3e and f), but TGF-b was
significantly higher in both the diabetic groups compared to
controls (p,0.01). No significant difference was seen in IL-10
levels among the three groups (Fig 3g).
Discussion
It is well known that individuals with diabetes are at increased
risk of susceptibility to several infectious diseases including
tuberculosis [12], urinary tract infection [13] and mucormycosis
[14]. It is generally assumed that diabetes increases the
susceptibility to all infections [2]. But in this study, we clearly
demonstrate that the prevalence of LF is lower in subjects with
type-2 diabetes. A serial decline in the prevalence of LF was seen
as individuals progressed from NGT to IGT to ND-DM to KDM
Table 2. Socioeconomic status of study subjects*.
Monthly Income
(Rs.)
NGT
%
IGT
%
ND-DM
%
KDM
%
LF+
%
LF2
%
,2000 32.9 33.3 25.2 39.7 33 32.5
2000–5000 50.1 46.1 54.8 51.6 49 50.4
5000–10000 14.5 15.6 17.0 4.8 16 13.8
10000–20000 2.0 3.5 2.2 3.2 2 2.6
.20000 0.5 1.4 0.7 0.8 NIL 0.7
*The occupation of the study subjects were collected as part of the CURES
questionnaire.
doi:10.1371/journal.pntd.0000707.t002
Table 1. Clinical and biochemical characteristics of study subjects.
PARAMETERS NGT (n=992) IGT (n=154) ND-DM (n=157) KD (n=160) p value
Age (yrs) 38.1613.2 47.2614.3 45.6611.3 50.6613.7 ,0.001
Sex (M/F) (%) 41.9/58.1 44.8/55.2 43.9/56.1 33.8/66.3 0.206
BMI (Kg/m
2) 22.764.3 24.964.6 25.764.4 25.464.1 ,0.001
Duration of diabetes --- 5 . 3 64.5 -
Systolic blood pressure (mmHg) 116.2618.2 128.7619.7 129.2618.0 127.4621.7 ,0.001
Diastolic blood pressure (mmHg) 72.4611.5 77.7611.1 79.4610.8 75.4612.2 ,0.001
Fasting plasma glucose (mg/dl) 83.967.8 94.7612.8 148.8662.1 162.1668.3 ,0.001
Glycated hemoglobin (%) 5.560.5 5.960.7 8.162.0 8.862.3 ,0.001
Total cholesterol (mg/dl) 174.2637.2 187.4636.2 198.5637.5 201.8639.0 ,0.001
Serum triglycerides (mg/dl) 109.8662.5 150.36113.9 184.86140.7 180.26130.6 ,0.001
High density lipoprotein cholesterol (mg/dl) 43.269.8 42.4612.2 40.567.4 41.669.3 ,0.01
Low density lipoprotein cholesterol (mg/dL) 109.1632.0 115.0634.1 121.0634.3 124.1639.0 ,0.001
Creatinine (mg/dL) 0.8860.38 0.8816 0.876.18 0.756.19 ,0.001
Microalbuminuria (mg/dL) 13.6629.3 18.7632.9 20.2626.0 37.3657.0 ,0.001
doi:10.1371/journal.pntd.0000707.t001
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and gender. The decrease in prevalence was associated with
decreased antigen load and anti-filarial IgG antibody titer but the
anti-filarial IgG4 titer was unaffected. The reduced IgG levels in
diabetic subjects was expected since previous reports have shown
reduced levels of IgG and increased levels of IgA among diabetic
subjects [15,16]. In terms of humoral responses, both subjects with
active filarial infection and those who are exposed but resistant to
infection mount vigorous antibody responses to parasite antigen,
most specifically, IgG4 [9,17]. Thus, BmA- specific IgG4 can be
considered to be a good surrogate marker for exposure. The fact
that IgG4 levels were not significantly different between the four
groups, is further evidence to show that, differences in exposure to
infection is less likely a reason for the differences in prevalence
between the diabetic and non-diabetic groups. It is very unlikely
that the decreased prevalence of LF among diabetic subjects was
due to LF-mediated mortality, as LF is a chronic, non-lethal
disease. Since, differences in socio-economic status could be a
confounding factor; the average monthly income and occupation
of the study subjects were analyzed. No significant difference was
seen between the study groups, indicating that, the socio-economic
status is unlikely to be a potential confounding factor for the
differences seen in the prevalence of LF. Another confounding
factor that could be of significance is the nutritional differences
[18] that could arise due to calorie restriction among diabetic
subjects. But, there was no difference with respect to average
protein intake (approximately 12%) among different groups, again
suggesting that nutritional differences or dietary intake are unlikely
to be potential confounding variables in the study. More likely is
the interplay between two chronic conditions in which the
longstanding regulatory environment seen in LF may play a role
in conferring resistance to type-2 diabetes. There are some reports
that have documented a similar inverse relationship between
diabetes and hepatitis C infection [19], but other studies failed to
reproduce the association [20]. More studies are thus needed on
the coincidence of diabetes and other infectious diseases to have a
better understanding about the interplay of infection/inflamma-
tion and diabetes.
Figure 1. Reduced prevalence of Lymphatic Filariasis (LF)
among diabetic individuals. Prevalence of filarial infection in
diabetic (DM-ND-Newly diagnosed and KDM-Known diabetic) and
non-diabetic (NGT-Normal glucose tolerance and IGT-Impaired glucose
tolerance) subjects was estimated (Panel a). The percentage of LF
positive individuals in each group is shown. Statistical difference in the
prevalence was determined by chi-square analysis. Filarial antigen levels
in diabetic (DM-ND-Newly diagnosed and KDM-Known diabetic) and
non-diabetic (NGT-Normal glucose tolerance and IGT-Impaired glucose
tolerance) subjects with active filarial infection (Panel b). Statistical
differences in the antigenic load were determined by Mann-Whitney U
test.
doi:10.1371/journal.pntd.0000707.g001
Figure 2. Anti-filarial antibody levels in diabetic (DM-ND-Newly
diagnosed and KDM-Known diabetic) and non-diabetic (NGT-
Normal glucose tolerance and IGT-Impaired glucose tolerance)
subjects with active filarial infection. Box and whisker plots of the
log transformed levels of IgG (Panel a) and IgG4 (Panel b) are shown for
each of the four groups. NS=Not significant. Statistical differences in
the antibody titer were determined by Mann-Whitney U test.
doi:10.1371/journal.pntd.0000707.g002
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prevent type-1 diabetes (‘‘hygiene hypothesis’’) [21], but whether
the same immunomodulatory effect can dampen inflammation
and protect against type-2 diabetes is currently not known. To
better understand the mechanism associated with the decreased
prevalence of LF among diabetic subjects, we studied the serum
cytokine levels. The main focus was to determine the effect of LF
on diabetes in terms of the serum cytokine profile. Although filarial
parasites elicit a broad spectrum of inflammatory and regulatory
responses mediated by cytokines, whether this type of immuno-
modulation occurs in co-incident diabetes has not been well-
studied. The serum cytokine profile of LF only patients has already
been reported by Satapathy et al. [22] and us, previously [23].
Diabetes in conjunction with LF had decreased levels of TNF-a
and IL-6 (cytokines that have already been associated with insulin
resistance (IR) [24]), compared to those with DM alone. Diabetic
subjects (without LF) had a typical pro-inflammatory phenotype
with high levels of TNF-a, IL-6 and GM-CSF. IL-1b, however,
was not elevated in these subjects, although it has been previously
been shown to act synergistically with TNF-a and IL-6 in inducing
IR [24]. The contribution of GM-CSF (seen to be elevated in
diabetic subjects) in mediating IR is currently not known.
Interestingly, in those with both diabetes and LF, the pro-
inflammatory cytokines - TNF-a, IL-6 and GM-CSF were
reduced, compared to those without LF, suggesting that LF-
mediated reduction of pro-inflammatory cytokines negatively
influences the development of IR.
Although pro-inflammatory cytokine levels are typically elevat-
ed in diabetic subjects, the data on the balance of effector T cell
phenotypes in this condition has been confusing with some studies
reporting Th1 polarization [25], others reporting Th2 skewing
[26], and still others reporting a balanced response [27]. In the
present study, diabetic subjects (who were LF negative) had very
high levels of IFN-c and IL-13 suggestive of a mixed (relatively
Figure 3. Pro- and anti - inflammatory serum cytokine levels in control (DM
2LF
2), diabetes alone (DM
+LF
2) and diabetes and LF
(DM
+LF
+) subjects. Serum levels of TNF-a (Panel a), IL-6 (Panel b), GM-CSF (Panel c), IFN-c (Panel d), IL-13 (Panel e), TGF-b (Panel f) and IL-10 (Panel
g) are shown. Each dot represents an individual patient, with the geometric mean represented by the horizontal bars. p values were calculated by
multinomial logistic regression analysis.
doi:10.1371/journal.pntd.0000707.g003
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cause or effect of IR remains to be established.
Although the anti-inflammatory cytokines - IL-10 and TGF-b -
have largely been associated with immune-regulation in LF (with
IL-10 playing the major role), the down regulation of pro-
inflammatory cytokines in type-2 diabetic subjects with LF seems
to be due to TGF-b and not IL-10. However, as TGF-b is often
elevated in diabetic subjects, other immunomodulatory molecules
such as CTLA-4, PD-1, IDO might act in concert with TGF-b in
the modulation of the immune responses in these groups [28].
Our study suggests that one mechanism by which LF can
potentially protect against type-2 diabetes, is by modulating the
pro-inflammatory environment seen in diabetes. Helminth
infections, such as LF could modulate diabetes by inducing a
chronic, non-specific, low-grade, immune regulation mediated by
Th2/Tregs (modified Th2 response) which in turn can suppress
the pro-inflammatory responses [29]. One can speculate that,
childhood filarial infection reduces TNF-a, IL-6 and GM-CSF
levels thereby conferring protection against type-2 diabetes. An
alternate hypothesis could be that the inflammation associated
with diabetes may also promote anti-filarial immunity by
enhancing anti-filarial antibody responses that could mediate
parasite clearance [30].
Although this study suffers from the limitation of being a cross-
sectional study and therefore not providing a direct causative
mechanism for the decreased prevalence of LF among diabetic
subjects, the study highlights the importance of the need to
understand the complex interactions between an infectious disease
(LF) and a metabolic disorder (Type-2 diabetes). In addition, the
immune as well as non-immune mechanisms by which the
interplay between LF and DM occurs needs to be explored in
detail. Finally, the decreasing incidence of LF (due to mass
eradication programs) could have an impact on the incidence of
type-2 diabetes in the future and obviously this is an important
area for future study.
Supporting Information
Table S1 The occupation of the study subjects were collected as
part of the CURES questionnaire.
Found at: doi:10.1371/journal.pntd.0000707.s001 (0.05 MB
DOC)
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